Omalizumab: an underutilized treatment option in bullous pemphigoid patients with co-morbidities

被引:15
|
作者
De, D. [1 ]
Kaushik, A. [1 ]
Handa, S. [1 ]
Mahajan, R. [1 ]
Schmidt, E. [2 ,3 ]
机构
[1] Postgrad Inst Med Educ & Res, Dept Dermatol Venereol & Leprol, Chandigarh, India
[2] Univ Lubeck, Dept Dermatol, Lubeck, Germany
[3] Univ Lubeck, Lubeck Inst Expt Dermatol LIED, Lubeck, Germany
关键词
IGE;
D O I
10.1111/jdv.17229
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
引用
收藏
页码:E469 / E472
页数:4
相关论文
共 50 条
  • [21] Dramatic exacerbation of bullous pemphigoid following rituximab and successful treatment with omalizumab
    Maglie, Roberto
    Antiga, Emiliano
    Quintarelli, Lavinia
    Verdelli, Alice
    Caproni, Marzia
    EUROPEAN JOURNAL OF DERMATOLOGY, 2019, 29 (02) : 213 - 215
  • [22] Dramatic exacerbation of bullous pemphigoid following rituximab and successful treatment with omalizumab
    Roberto Maglie
    Emiliano Antiga
    Lavinia Quintarelli
    Alice Verdelli
    Marzia Caproni
    European Journal of Dermatology, 2019, 29 : 213 - 215
  • [23] Rituximab, Omalizumab, and Dupilumab Treatment Outcomes in Bullous Pemphigoid: A Systematic Review
    Cao, Peng
    Xu, Wenjing
    Zhang, Litao
    FRONTIERS IN IMMUNOLOGY, 2022, 13
  • [24] Omalizumab as an alternative therapeutic tool in the treatment of bullous pemphigoid: A case report
    Vico-Alonso, Cristina
    Calleja-Algarra, Alba
    Aragon-Miguel, Raquel
    Sanchez-Velazquez, Alba
    Velasco-Tamariz, Virginia
    Luis Ortiz-Romero, Pablo
    Monsalvez-Honrubia, Veronica
    DERMATOLOGIC THERAPY, 2019, 32 (02)
  • [25] Feline Hyperthyroidism - Treatment Options Co-morbidities
    von Fircks, Anna Lena
    von Luckner, Jennifer
    KLEINTIERPRAXIS, 2023, 68 (06): : 298 - 313
  • [26] CO-MORBIDITIES AND COMPLICATIONS OF DISEASE AND/OR TREATMENT: BONE
    McGinty, Tara
    Cotter, Aoife
    Sabin, Caroline
    Lambert, Jack
    Sheehan, Gerard
    Macken, Alan
    Kavanagh, Eoin
    Compston, Juliet
    Mallon, Paddy
    JOURNAL OF THE INTERNATIONAL AIDS SOCIETY, 2016, 19
  • [27] Special considerations in the treatment of patients with bipolar disorder and medical co-morbidities
    McLaren K.D.
    Marangell L.B.
    Annals of General Hospital Psychiatry, 3 (1):
  • [28] Narcolepsy: Clinical features, co-morbidities & treatment
    Peacock, Jeremy
    Benca, Ruth M.
    INDIAN JOURNAL OF MEDICAL RESEARCH, 2010, 131 (02) : 338 - 349
  • [29] CO-MORBIDITIES MAY NOT CHANGE TREATMENT CHARACTERISTICS OF THE RHEUMATOID ARTHRITIS PATIENTS
    Tezcan, M. E.
    Gecmez, G.
    Volkan, O.
    Sen, N.
    Yilmaz-Oner, S.
    ANNALS OF THE RHEUMATIC DISEASES, 2021, 80 : 514 - 515
  • [30] Co-morbidities at patients with sleep apnoea syndrome
    Ardelean, C. L.
    Dimitriu, D. R.
    Frent, S. M.
    Petriu, M.
    Tudorache, V.
    Lighezan, D. F.
    Mihaicuta, S.
    JOURNAL OF SLEEP RESEARCH, 2012, 21 : 285 - 286